Histidine-Proline Rich Glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells

Summary

The anti-angiogenic properties of the histidine-proline–rich (H/P) domain of HPRG have recently been described (Juarez JC, et al. Cancer Research 2002; 62: 5344-50). However, the binding site that mediates these properties is unknown. HPRG is evolutionarily, functionally and structurally related to cleaved high molecular weight kininogen (HKa), an anti-angiogenic polypeptide that stimulates apoptosis of proliferating endothelial cells through binding to cell-surface tropomyosin (Zhang J-C, et al. Proc Natl Acad Sci USA 2002; 99: 12224-9). In this study, we demonstrate that HPRG binds with high affinity to FGF-2–stimulated human umbilical vein endothelial cells (HUVEC) and immobilized tropomyosin in a Zn²⁺ or pH-dependent manner, and that this interaction is mediated by the H/P domain of HPRG. At least two binding sites for HPRG, tropomyosin and heparan sulfate proteoglycans (HSPs), were identified on the surface of FGF-2–activated endothelial cells. Translocation of tropomyosin to the surface of HUVEC occurred in response to FGF-2, and the anti-angiogenic activity of HPRG in a Matrigel plug model was partially inhibited by soluble tropomyosin. These results suggest that HPRG binds to endothelial cell surface tropomyosin which at least partially mediates the antiangiogenic effects of HPRG.

Keywords

HPRG - angiogenenesis - endothelial cells - tropomyosin

• References

• 1 Juarez JC, Guan X, Shipulina NV. et al. Histidine-proline-rich glycoprotein has potent anti-angiogenic activity mediated through the histidine-proline-rich domain. Cancer Res 2002; 62 (18) 5344-5350.
• 2 Olsson AK, Larsson H, Dixelius J. et al. A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Cancer Res 2004; 64 (02) 599-605.
• 3 Morgan WT. Histidine-Rich Glycoprotein. Wiley Encyclopedia of Molecular Medicine. New York: John Wiley & Sons, Inc; 2002: 1644-1647.
• 4 Leung L. Histidine-rich glycoprotein: an abundant plasma protein in search of a function. J Lab Clin Med 1993; 121 (05) 630-631.
• 5 Leung LL. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 1986; 77 (04) 1305-1311.
• 6 Borza DB, Morgan WT. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-prolinerich glycoprotein. J Biol Chem 1997; 272 (09) 5718-5726.
• 7 Leung LL, Nachman RL, Harpel PC. Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest 1984; 73 (01) 5-12.
• 8 Brown KJ, Parish CR. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor. Biochemistry 1994; 33 (46) 13918-27.
• 9 Borza DB, Morgan WT. Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by ph and metals. J Biol Chem 1998; 273 (10) 5493-5499.
• 10 Morgan WT. The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals. Biochemistry 1985; 24 (06) 1496-1501.
• 11 Lijnen HR, Hoylaerts M, Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem 1980; 255 (21) 10214-22.
• 12 Borza DB, Tatum FM, Morgan WT. Domain structure and conformation of histidine-proline-rich glycoprotein. Biochemistry 1996; 35 (06) 1925-1934.
• 13 Horne III MK, Merryman PK, Cullinane AM. Histidine-proline-rich glycoprotein binding to platelets mediated by transition metals. Thromb Haemost 2001; 85 (05) 890-895.
• 14 Lamb-Wharton RJ, Morgan WT. Induction of T-lymphocyte adhesion by histidine-prolinerich glycoprotein and concanavalin A. Cell Immunol 1993; 152 (02) 544-555.
• 15 Olsen HM, Parish CR, Altin JG. Histidine-rich glycoprotein binding to T-cell lines and its effect on T-cell substratum adhesion is strongly potentiated by zinc. Immunology 1996; 88 (02) 198-206.
• 16 Zhang JC, Claffey K, Sakthivel R. et al. Twochain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J 2000; 14 (15) 2589-2600.
• 17 Zhang JC, Qi X, Juarez J. et al. Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogenderived polypeptides. Can J Physiol Pharmacol 2002; 80 (02) 85-90.
• 18 Zhang JC, Doñate F, Qi X. et al. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin. Proc Natl Acad Sci USA 2002; 99 (19) 12224-9.
• 19 Novy RE, Sellers JR, Liu LF. et al. In vitro functional characterization of bacterially expressed human fibroblast tropomyosin isoforms and their chimeric mutants. Cell Motil Cytoskeleton 1993; 26 (03) 248-261.
• 20 Novy RE, Liu LF, Lin CS. et al. Expression of smooth muscle and nonmuscle tropomyosins in Escherichia coli and characterization of bacterially produced tropomyosins. Biochim Biophys Acta 1993; 1162 (03) 255-265.
• 21 Lin JJ, Warren KS, Wamboldt DD. et al. Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol 1997; 170: 1-38.
• 22 Stringer SE, Gallagher JT. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J Biol Chem 1997; 272 (33) 20508-14.
• 23 MacDonald NJ. et al. Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin. J Biol Chem 2001; 276 (27) 25190-6.
• 24 Gorodetsky R. et al. Platelet multielemental composition, lability, and subcellular localization. Am J Hematol 1993; 42 (03) 278-283.
• 25 LaManna JC. Hypoxia/ischemia and the pH paradox. Adv Exp Med Biol 1996; 388: 283-292.
• 26 Kuo HW, Chen SF, Wu CC. et al. Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res 2002; 89 (01) 1-11.
• 27 Poo JL, Rosas-Romero R, Montemayor AC. et al. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study. J Gastroenterol 2003; 38 (01) 45-51.
• 28 Onuma EK, Amenta PS, Ramaswamy K. et al. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5. Clin Exp Immunol 2000; 121 (03) 466-471.
• 29 Kesari KV, Yoshizaki N, Geng X. et al. Externalization of tropomyosin isoform 5 in colon epithelial cells. Clin Exp Immunol 1999; 118 (02) 219-227.
• 30 Moser TL, Stack MS, Asplin I. et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999; 96 (06) 2811-2816.
• 31 Moser TL. et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001; 98 (12) 6656-6661.
• 32 Kim J, Hajjar KA. Annexin II: a plasminogenplasminogen activator co-receptor. Front Biosci 2002; 07: d341-d348.
• 33 Tuszynski GP, Sharma MR, Rothman VL. et al. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells. Microvasc Res 2002; 64 (03) 448-462.
• 34 Asea A. et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277 (17) 15028-34.
• 35 Kozawa O, Matsuno H, Niwa M. et al. HSP20, low-molecular-weight heat shock-related protein, acts extracellularly as a regulator of platelet functions: a novel defense mechanism. Life Sci 2002; 72 (02) 113-124.
• 36 Moroianu J, Fett JW, Riordan JF, Vallee BL. Actin is a surface component of calf pulmonary artery endothelial cells in culture. Proc Natl Acad Sci USA 1993; 90 (09) 3815-3819.
• 37 Moses MA, Wiederschain D, Wu I. et al. Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci USA 1999; 96 (06) 2645-2650.
• 38 Feldman L, Rouleau C. Troponin I inhibits capillary endothelial cell proliferation by interaction with the cell’s bFGF receptor. Microvasc Res 2002; 63 (01) 41-49.
• 39 Pearlstone JR, Smillie LB. Effects of troponin-I plus-C on the binding of troponin-T and its fragments to alpha-tropomyosin. Ca2+ sensitivity and cooperativity. J Biol Chem 1983; 258 (04) 2534-2542.